In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II

Anti-cancer Drugs
Prakash MistryPeter A Charlton

Abstract

XR11576, a novel phenazine, was developed as an inhibitor of both topoisomerase I and II. This study characterized the ability of XR11576 to inhibit both enzymes, and determined its in vitro and in vivo antitumor efficacy against a number of murine and human tumor models. XR11576 was a potent inhibitor of purified topoisomerase I and IIalpha, and exhibited similar potency for both enzymes. The compound stabilized enzyme-DNA cleavable complexes indicating that it acted as a topoisomerase poison. The DNA cleavage patterns obtained with XR11576 were different from those induced by camptothecin and etoposide, which are topoisomerase I and II poisons, respectively. XR11576 demonstrated potent cytotoxic activity against a variety of human and murine tumor cell lines (IC50=6-47 nM). Its activity profile was comparable to or better than that of many widely used anticancer drugs. Moreover, XR11576 was unaffected by multidrug resistance (MDR) mediated by overexpression of either P-glycoprotein or MDR-associated protein, or by down-regulation of topoisomerase II. The latter property supports the dual inhibitory mechanism of action of the compound. XR11576 exhibited a similar pharmacokinetic profile in mice and rats after either i.v. or p....Continue Reading

References

Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M M HeckW C Earnshaw
Dec 1, 1994·International Journal of Cancer. Journal International Du Cancer·H L McLeodW N Keith
Nov 1, 1994·The Biochemical Journal·P M Watt, I D Hickson
Nov 1, 1993·Current Opinion in Oncology·M D'Incalci
Apr 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G J FinlayB C Baguley
Jan 1, 1996·Annual Review of Biochemistry·J C Wang
Sep 28, 1998·Biochimica Et Biophysica Acta·T Andoh, R Ishida
Jul 3, 1999·Japanese Journal of Cancer Research : Gann·Y AoyagiY Yamada
Mar 4, 2000·Progress in Nucleic Acid Research and Molecular Biology·J M Fortune, N Osheroff

❮ Previous
Next ❯

Citations

Aug 6, 2008·Cancer Chemotherapy and Pharmacology·Andrew G JobsonCaroline A Austin
Dec 21, 2002·Nuclear Medicine and Biology·Dale O KiesewetterWilliam C Eckelman
Dec 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F CaponigroP Fumoleau
Nov 5, 2011·The American Journal of the Medical Sciences·Li ZhangQi Su
Aug 6, 2005·Biopharmaceutics & Drug Disposition·Val R BeasleyJeffrey M Levengood
Mar 16, 2011·The Journal of Pharmacy and Pharmacology·Sazal PatyarBikash Medhi
May 24, 2008·Journal of Lipid Research·Sarah T PruettAlfred H Merrill
Dec 13, 2006·Anti-cancer Drugs·Louisa J LewisHelen M Coley
May 24, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M von MehrenR B Cohen
Jun 3, 2004·British Journal of Cancer·G TarabolettiR Giavazzi
Jul 2, 2003·Amino Acids·Y L Janin
Jun 18, 2010·Expert Review of Anticancer Therapy·Josep M Del CampoAna Oaknin
Jun 8, 2018·Current Medicinal Chemistry·Tijana StankovićMilica Pešić
Oct 1, 2004·Anti-cancer Drugs·Federica Di NicolantonioIan A Cree
Aug 20, 2004·The Journal of Biological Chemistry·Jixun DaiDanzhou Yang
Oct 6, 2004·International Journal of Immunopathology and Pharmacology·E L CooperM Grdisa
Jul 19, 2019·Analytical and Bioanalytical Chemistry·Kyril M SolntsevShady A Amin
Jan 16, 2007·Molecular Cancer Therapeutics·Chandanamali PunchihewaDanzhou Yang
Feb 23, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sabrina DallavalleRoberta Fruttero
Jul 30, 2004·Organic Letters·Shi-Jun Wen, Zhu-Jun Yao
Jul 3, 2008·Journal of Agricultural and Food Chemistry·Wenyi WangElvira Gonzalez de Mejia
Nov 3, 2021·Molecular Cancer Therapeutics·Katja KlauszMatthias Peipp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.